APC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.263600E-01
Normal-vs-Stage2
2.904600E-01
Normal-vs-Stage3
1.086350E-01
Normal-vs-Stage4
7.647800E-01
Stage1-vs-Stage2
1.055820E-01
Stage1-vs-Stage3
1.039580E-02
Stage1-vs-Stage4
7.466800E-01
Stage2-vs-Stage3
9.71530000000165E-05
Stage2-vs-Stage4
7.676200E-02
Stage3-vs-Stage4
1.015840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.995600E-01
Normal-vs-AfricanAmerican
8.052000E-01
Normal-vs-Asian
2.214400E-01
Caucasian-vs-AfricanAmerican
4.534000E-01
Caucasian-vs-Asian
4.147000E-01
AfricanAmerican-vs-Asian
2.640000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.204200E-01
Normal-vs-Female
4.093000E-01
Male-vs-Female
8.771400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.250200E-01
Normal-vs-Age(41-60Yrs)
7.223800E-01
Normal-vs-Age(61-80Yrs)
3.208200E-01
Normal-vs-Age(81-100Yrs)
5.943600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.067400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.769800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.497800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.310100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.601900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.903200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.414000E-02
Normal-vs-Daily Drinker
5.942200E-02
Normal-vs-Weekly Drinker
3.168400E-01
Normal-vs-Occasional Drinker
7.119800E-01
Normal-vs-Social Drinker
8.708800E-01
Non Drinker-vs-Daily Drinker
5.424400E-01
Non Drinker-vs-Weekly Drinker
5.588800E-01
Non Drinker-vs-Occasional Drinker
5.676000E-02
Non Drinker-vs-Social Drinker
1.106960E-01
Daily Drinker-vs-Weekly Drinker
3.239000E-01
Daily Drinker-vs-Occasional Drinker
3.160100E-02
Daily Drinker-vs-Social Drinker
6.314300E-02
Weekly Drinker-vs-Occasional Drinker
3.311000E-01
Weekly Drinker-vs-Social Drinker
2.873000E-01
Occasional Drinker-vs-Social Drinker
7.938000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.161800E-01
Normal-vs-Grade 2
9.090000E-02
Normal-vs-Grade 3
6.790100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.596200E-01
Grade 1-vs-Grade 3
5.915800E-01
Grade 1-vs-Grade 4
2.161800E-01
Grade 2-vs-Grade 3
9.629600E-01
Grade 2-vs-Grade 4
9.090000E-02
Grade 3-vs-Grade 4
6.790100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.685000E-01
Normal-vs-NonDiabetic
3.597600E-01
Diabetic-vs-NonDiabetic
6.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.287840E-01
Normal-vs-NoPancreatitis
3.851200E-01
Pancreatitis-vs-NoPancreatitis
4.414800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.792400E-01
Normal-vs-N1
3.118400E-01
N0-vs-N1
5.263000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.945800E-01
Normal-vs-TP53-NonMutant
8.701600E-01
TP53-Mutant-vs-TP53-NonMutant
6.247900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
